Topic: artificial intelligence
In two studies, researchers used machine learning to spot and classify cells—as well as their hidden, internal structures and DNA—using images alone.
Machine learning identified mutations in 60 genes that raise the risk of abdominal aortic aneurysm (AAA).
Researchers showed AI can predict therapy responses using a radiomic biomarker, by analyzing CT images for prior immune system infiltration of tumors.
A trio of aging-focused biotechs and research firms formed a joint venture to develop small molecules for a novel target hoping to extend life spans.
Former Fierce 15 winner MaxQ plans to go public with $8 million IPO, as it awaits FDA approval of its AI tech for analyzing CT scans for brain bleeds.
Sensyne Health plans to go public with a £60 million listing ($77 million) on the London Stock Exchange on Aug. 17.
An AI startup raised $1 million to develop “machine reading” programs to digest and distill published biomedical literature and research.
Two AI firms, Insilico Medicine and A2A Pharmaceuticals, launched a joint company aimed at Duchenne muscular dystrophy and other rare orphan diseases.
IBM and the VA extended their precision oncology partnership in applying Watson technology to the treatment of veterans with late-stage cancer.
Viz.ai, an AI company developing software to detect strokes, has raised $21 million in venture capital to expand its reach to other conditions.